Child Health News

RSS

Obesity research targeting 3 to 5 year olds

A ground-breaking study at the University of Wollongong, Australia is targeting factors affecting the development of obesity in young pre-school children aged between three and five.

28 Mar 2004

Groundbreaking work on the development of motor skills in infants is being expanded to include at-risk children

For the last three years, Galloway and his graduate students have been studying the early motor skills of infants and have found that the encouragement of movement very early in life can spur physical development.

27 Mar 2004

Texan child receives world's first scaled-down heart pump or child ventricular assist device

A six-year-old Texas Children's Hospital patient is the first pediatric patient in the world to receive a MicroMed/DeBakey® child ventricular assist device (VAD), recently approved by the FDA for use in children. The new, scaled-down heart pump improves blood flow for patients awaiting heart transplants.

27 Mar 2004

Children with sickle cell disease are living longer, dying less often from their disease

Children with sickle cell disease, an inherited red blood-cell disorder, are living longer, dying less often from their disease and contracting fewer fatal infections than ever before, researchers at UT Southwestern Medical Center at Dallas report. Their study, which will appear in the June edition of the scientific journal Blood, is the first to evaluate survival rates of children receiving the most modern treatments for sickle cell disease. It's also one of the largest published sickle cell studies to date. Researchers followed more than 700 Dallas-area children with the disease over two decades.

25 Mar 2004

Youth obesity provides food for thought

With heart disease developing among children from the age of 10 through poor diet and low activity, young Australians are part of what the World Health Organisation has already termed an "international epidemic of childhood obesity".

22 Mar 2004

FDA approves new chewable formulation of Zyrtec® aimed at young allergy sufferers

Pfizer Inc and UCB Pharma today announced the approval of a new chewable formulation of Zyrtec® (cetirizine HCl) for the treatment of seasonal and perennial allergic rhinitis (inflammation of the nasal passages) and chronic idiopathic urticaria (itching and hives of unknown causes) in children aged two years and older. The approval by the US Food and Drug Administration makes Zyrtec the first and only prescription antihistamine available in both syrup and chewable form.

22 Mar 2004

Study of three treatments of type 2 diabetes in children and teens has begun in US

A clinical study comparing three treatments of type 2 diabetes in children and teens has begun in 12 medical centers and their affiliated sites around the country, HHS Secretary Tommy G. Thompson announced today.

22 Mar 2004

Japanese study raises concerns for childhood health issues

The number of children suffering from mental disorders and health problems such as allergies and asthma has risen sharply over the past decade in this country. The United States and European countries are also facing the increasingly serious problems of premature births and childhood obesity, in addition to allergic reactions. Many experts say the rise in health problems involving children is related to the use of chemicals in our daily lives and the impact of medical treatment provided to the children's mothers.

22 Mar 2004

Child Health News

Obesity research targeting 3 to 5 year olds

Groundbreaking work on the development of motor skills in infants is being expanded to include at-risk children

Texan child receives world's first scaled-down heart pump or child ventricular assist device

Children with sickle cell disease are living longer, dying less often from their disease

Youth obesity provides food for thought

FDA approves new chewable formulation of Zyrtec® aimed at young allergy sufferers

Study of three treatments of type 2 diabetes in children and teens has begun in US

Japanese study raises concerns for childhood health issues

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News